Key result
Ductus arteriosus stenting maintains patency as a bridge to cardiac transplantation in HLHS.
Why the study?
In infants with hypoplastic left-heart syndrome considered for neonatal heart transplantation, patency of the ductus arteriosus must be maintained until a suitable donor organ becomes available.
Does stenting of the ductus arteriosus maintain ductal patency as a bridge to cardiac transplantation in infants with hypoplastic left-heart syndrome?
Does stenting of the ductus arteriosus maintain ductal patency as a bridge to cardiac transplantation in infants with hypoplastic left-heart syndrome?
Evaluates stenting of the ductus arteriosus to maintain ductal patency in infants with hypoplastic left-heart syndrome awaiting heart transplantation.
Answers are grounded in this paper and cite their sources.
May support Norwood or transplantation for hypoplastic left heart syndrome; leaves open optimal strategy pending higher-level evidence.
The hypoplastic left-heart syndrome is a complex congenital cardiac malformation1–3 that accounts for 7 to 8 percent of all cardiac lesions presenting in the first year of life; in addition, it is known to be the most common cause of death due to cardiac causes during the first week of life3–5. The prognosis has changed substantially since the development of the Norwood procedure in 19803,6–11 and the introduction of neonatal heart transplantation in 19853,12–14. When transplantation is considered, however, patency of the ductus arteriosus must be maintained until a suitable donor organ . . .
No takes yet. Share an insight, caveat, or question.
Ruiz et al. (1993) studied Hypoplastic left-heart syndrome. Stenting of the ductus arteriosus was evaluated on Patency of the ductus arteriosus as a bridge to cardiac transplantation. Stenting of the ductus arteriosus was evaluated to maintain ductal patency as a bridge to cardiac transplantation in infants with hypoplastic left-heart syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: